company background image
C34 logo

Carasent DB:C34 Stock Report

Last Price

€1.56

Market Cap

€114.9m

7D

2.3%

1Y

26.6%

Updated

04 Jul, 2024

Data

Company Financials +

C34 Stock Overview

Provides cloud based electronic health record solutions to the health care industry in Sweden, Norway, and internationally.

C34 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance0/6
Financial Health6/6
Dividends2/6

Carasent ASA Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Carasent
Historical stock prices
Current Share PriceNOK 1.56
52 Week HighNOK 1.64
52 Week LowNOK 0.84
Beta0.47
11 Month Change-0.64%
3 Month Change70.31%
1 Year Change26.62%
33 Year Change-52.29%
5 Year Changen/a
Change since IPO-27.44%

Recent News & Updates

Recent updates

Shareholder Returns

C34DE Healthcare ServicesDE Market
7D2.3%-1.5%0.6%
1Y26.6%-25.9%3.3%

Return vs Industry: C34 exceeded the German Healthcare Services industry which returned -25.9% over the past year.

Return vs Market: C34 exceeded the German Market which returned 3.3% over the past year.

Price Volatility

Is C34's price volatile compared to industry and market?
C34 volatility
C34 Average Weekly Movement13.7%
Healthcare Services Industry Average Movement3.8%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.4%
10% least volatile stocks in DE Market2.5%

Stable Share Price: C34's share price has been volatile over the past 3 months.

Volatility Over Time: C34's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
1997165Daniel Ohmancarasent.com

Carasent ASA provides cloud based electronic health record solutions to the health care industry in Sweden, Norway, and internationally. The company offers Webdoc, a cloud-based EHR system; Metodika EPM, a solution designed for mid-to-large-sized organizations; Medrave M4 to give healthcare staff and managers an overview and clear picture of the patient group being treated; Health Profile Institute AB (HPI), an occupational care platform; Ad Curis, a record system with digital services tailored for the specialist healthcare service with clients in rehabilitation, interdisciplinary specialized drug treatment, and mental health care, as well as businesses in care and prevention; and Ad Opus, a journal system for follow-up of participants in measures. It also provides platform services, such as Vårdrummet, Confrere, Ad Voca, electronic letters, SMS services, portal to medical services, and consulting and other services.

Carasent ASA Fundamentals Summary

How do Carasent's earnings and revenue compare to its market cap?
C34 fundamental statistics
Market cap€114.86m
Earnings (TTM)-€4.90m
Revenue (TTM)€21.96m

5.2x

P/S Ratio

-23.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
C34 income statement (TTM)
RevenueNOK 250.95m
Cost of RevenueNOK 45.08m
Gross ProfitNOK 205.87m
Other ExpensesNOK 261.83m
Earnings-NOK 55.96m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Jul 12, 2024

Earnings per share (EPS)-0.77
Gross Margin82.04%
Net Profit Margin-22.30%
Debt/Equity Ratio0%

How did C34 perform over the long term?

See historical performance and comparison

Dividends

10.1%

Current Dividend Yield

-243%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.